Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cosby A Stone

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|September 23, 2020
Safety, Efficacy, and Effectiveness of Delabeling in Patients with Multiple Drug Allergy LabelsChandra Vethody, Roger Yu, Jacob M Keck, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Seasonality and Trends in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Before and During the COVID-19 Pandemic: A Pharmacovigilance StudyEric Milan Mukherjee, Dodie Park, Matthew S Krantz, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 1, 2020
Children with reported penicillin allergy: Public health impact and safety of delabelingDavid Vyles, James W Antoon, Allison Norton, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 14, 2023
Identifying and Managing Those at Risk for Vaccine-Related Allergy and AnaphylaxisCosby A Stone, Lene H Garvey, Shuaib Nasser, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Characterization of Demographics, Drug Latency, and Mortality of Severe Cutaneous Adverse Reactions in an FDA Pharmacovigilance DatabaseEric M Mukherjee, Dodie Park, Matthew S Krantz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 8, 2025
Direct oral challenges safely reduce the burden of low-risk cephalosporin allergy labelsJason Moraczewski, Rebecca Lee, Grace Koo, et al.
JAMA Network Open|February 3, 2026
High-Risk Penicillin Reaction Flags in the Medical RecordSamantha Novotny, Lina Elmansy, Jason Kwah, et al.
Allergy|May 24, 2021
Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don't give up on the second dose!Matthew S Krantz, Maria A Bruusgaard-Mouritsen, Grace Koo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 19, 2023
Quantification of peanut allergens across recalled and nonrecalled lots of diagnostic peanut extractsCosby A Stone, Jonathan A Hemler, Stephanie Filep, et al.
British Journal of Clinical Pharmacology|March 28, 2017
Pharmacogenomics of off-target adverse drug reactionsSarah L Garon, Rebecca K Pavlos, Katie D White, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Allergy and Clinical Immunology. in Practice|September 23, 2020
Safety, Efficacy, and Effectiveness of Delabeling in Patients with Multiple Drug Allergy LabelsChandra Vethody, Roger Yu, Jacob M Keck, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Seasonality and Trends in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Before and During the COVID-19 Pandemic: A Pharmacovigilance StudyEric Milan Mukherjee, Dodie Park, Matthew S Krantz, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 1, 2020
Children with reported penicillin allergy: Public health impact and safety of delabelingDavid Vyles, James W Antoon, Allison Norton, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 14, 2023
Identifying and Managing Those at Risk for Vaccine-Related Allergy and AnaphylaxisCosby A Stone, Lene H Garvey, Shuaib Nasser, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Characterization of Demographics, Drug Latency, and Mortality of Severe Cutaneous Adverse Reactions in an FDA Pharmacovigilance DatabaseEric M Mukherjee, Dodie Park, Matthew S Krantz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 8, 2025
Direct oral challenges safely reduce the burden of low-risk cephalosporin allergy labelsJason Moraczewski, Rebecca Lee, Grace Koo, et al.
JAMA Network Open|February 3, 2026
High-Risk Penicillin Reaction Flags in the Medical RecordSamantha Novotny, Lina Elmansy, Jason Kwah, et al.
Allergy|May 24, 2021
Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don't give up on the second dose!Matthew S Krantz, Maria A Bruusgaard-Mouritsen, Grace Koo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 19, 2023
Quantification of peanut allergens across recalled and nonrecalled lots of diagnostic peanut extractsCosby A Stone, Jonathan A Hemler, Stephanie Filep, et al.
British Journal of Clinical Pharmacology|March 28, 2017
Pharmacogenomics of off-target adverse drug reactionsSarah L Garon, Rebecca K Pavlos, Katie D White, et al.
Pageof 12